Celiac Disease Foundation Teams Up with Mark Cuban Cost Plus Drug Company

The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206060059/en/

Currently, there is no medication, treatment, or cure for celiac disease, nor is there an effective method for prevention. The only course of action to avoid intestinal damage – and the increased risks of a variety of other diseases, including cancer – is to follow a strict gluten-free diet, which includes food and medications for any other conditions they might have.

“Advocating for the needs of the celiac disease patient community is at the core of our mission,” said Foundation CEO Marilyn G. Geller. “Coupled with our robust government affairs program and policy initiatives, the Celiac Disease Foundation is also proactively pursuing alternatives and partnerships in the private sector, doing our utmost to ensure that patients feel confident about taking necessary medications without worrying about ingesting gluten. We are pleased and proud to join forces with Mark Cuban Cost Plus Drug Company to provide peace of mind to our celiac disease community.”

Cost Plus Drugs’ pharmacy fulfillment partners can address inquiries regarding gluten content in medications, ensuring that those with celiac disease can confidently navigate their needs with the guidance of knowledgeable pharmacists.

“We are thrilled to be working with the Celiac Disease Foundation,” said Dr. Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “At Cost Plus Drugs, we believe in the power of collaboration to create positive change. Teaming up with the Celiac Disease Foundation supports our commitment to making healthcare accessible and affordable for all.”

Since 1990 the Celiac Disease Foundation has been committed to accelerating diagnosis, treatments, and a cure for celiac disease – one of the world’s most prevalent genetic autoimmune diseases that affects an estimated 3 million Americans, 70-80% of whom are undiagnosed. Living with celiac disease is a daily struggle, and it also increases the mortality risks for cancer, cardiovascular disease, and respiratory disease. Beyond mortality risk, celiac disease is also associated with an increased risk of additional autoimmune diseases and cancers such as intestinal malignancy and lymphoma.

To learn more about the Celiac Disease Foundation, visit celiac.org and follow the Foundation’s social media on Facebook, Twitter/X, Instagram, and Threads.

About the Celiac Disease Foundation

The Celiac Disease Foundation, established in 1990, is a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease. Our mission is to improve the health and well-being of the millions of individuals around the world affected by this genetic autoimmune disease through our strategic investments in research, advocacy, and education. Our iCureCeliac® Patient Registry and extensive patient recruitment services at iRecruitCeliac.org enable us to identify qualified patient candidates and speed their enrollment to advance critical disease research. Our unparalleled advocacy program has led the way to secure federal recognition and first-ever research funding from agencies including the U.S. National Institutes of Health and the Department of Defense. We adhere to the highest scientific and ethical standards as we work each day to promote understanding of celiac disease, empower our patient and provider community, and collaborate with partners and stakeholders to carry our mission forward.

About Mark Cuban Cost Plus Drug Company

The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates. As a public-benefit corporation, its social mission of improving public health is just as important as the bottom line. Cost Plus Drugs transparently charges a standard markup on every drug it sells. The costplusdrugs.com online pharmacy launched in January 2022 now carries over 1,000 prescription products, delivered by mail to thousands of happy customers every day. Cost Plus Drugs is working with health plans, managed-care organizations, pharmacy benefits managers (PBMs) and self-insured employers to bring these same savings to employer-sponsored benefit plans nationwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231206060059/en/